Clinical Trials Directory

Trials / Terminated

TerminatedNCT01639664

COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2

COMPACT (COMbining Plasma-filtration and Adsorption Clinical Trial): Efficacy and Safety of High Doses CPFA (Coupled Plasma Filtration Adsorption) for Septic Shock in the ICU

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
115 (actual)
Sponsor
Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

The study objective is to clarify whether the application of high doses CPFA (coupled plasma-filtration adsorption) in addition to the current clinical practice is able to reduce hospital mortality in septic shock patients in intensive care unit (ICU).

Detailed description

Septic shock is a life-threatening clinical condition characterized by cardiovascular failure as a consequence of infection. Septic shock frequently causes multi-organ failure in the ICU. For this reason the extracorporeal therapies for the treatment of renal failure have become widespread in the ICU and, at the same time, new extracorporeal depurative techniques have been developed for the removal of inflammatory mediators. One of these techniques is CPFA (coupled plasma-filtration adsorption) that uses a sorbent once the separation between plasma and blood has been obtained with a plasma filter. The study objective is to clarify whether the application of high doses CPFA in addition to the current clinical practice is able to reduce hospital mortality in septic shock patients in intensive care unit. Secondary objectives are the resolution of septic shock and the reduction of ICU LOS (length of stay).

Conditions

Interventions

TypeNameDescription
DEVICEHigh doses CPFAHigh doses CPFA (coupled plasma-filtration adsorption) with AMPLYA™ (BELLCO ITALY): \>0.20 L/kg/day of plasma treated in the first 3 days after randomization.

Timeline

Start date
2013-09-01
Primary completion
2017-10-23
Completion
2017-10-23
First posted
2012-07-13
Last updated
2021-09-05
Results posted
2021-09-05

Locations

13 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT01639664. Inclusion in this directory is not an endorsement.